Stachecki James J, Garrisi John, Sabino Sandro, Caetano Joao P J, Wiemer Klaus E, Cohen Jacques
Tyho-Galileo Research Laboratories, 3 Regent Street, Suite 301, Livingston, NJ 07039, USA.
Reprod Biomed Online. 2008 Sep;17(3):360-7. doi: 10.1016/s1472-6483(10)60219-2.
This study examined a new method for vitrification of blastocysts that is safe, simple and easy to learn and use. Current vitrification techniques have shortcomings that include the use of dimethyl sulphoxide, one of the more toxic cryoprotectants, and minute containers that are difficult to handle and are usually open to contamination. Cell handling and loading times are very short, which allows no room for user-associated errors and increases the difficulty of the procedure. This study describes a method of vitrification without these shortcomings. Human and bovine blastocysts were exposed to a series of three cryoprotectant solutions and loaded into a 0.25 ml sterile straw, heat sealed at both ends and vitrified. This technique allowed sufficient time for cryoprotectant exposure, loading, sealing and vitrification. Research blastocysts were thawed, cultured for 24 h, and stained for cell viability. The majority survived and on average had few lysed cells. In clinical studies from three different centres, 81.4% of vitrified blastocysts were intact after thawing. Out of 43 transfers with 76 blastocysts replaced, 44.7% implanted, 43.4% yielded a fetal heart beat, and a total of 32 babies have been delivered or are ongoing. The overall clinical pregnancy per transfer rate was 60.4%. The high survival rates and clinical pregnancy rates obtained with this new, safe and easy-to-use vitrification procedure are encouraging.
本研究考察了一种用于囊胚玻璃化冷冻的新方法,该方法安全、简单且易于学习和使用。当前的玻璃化冷冻技术存在一些缺点,包括使用毒性较强的冷冻保护剂之一二甲基亚砜,以及难以操作且通常易受污染的微小容器。细胞处理和装载时间非常短,这使得用户相关误差没有空间,增加了操作难度。本研究描述了一种不存在这些缺点的玻璃化冷冻方法。将人类和牛的囊胚暴露于一系列三种冷冻保护剂溶液中,然后装入0.25毫升无菌吸管,两端热封并进行玻璃化冷冻。该技术为冷冻保护剂暴露、装载、密封和玻璃化冷冻留出了足够的时间。研究用的囊胚解冻后培养24小时,并对细胞活力进行染色。大多数囊胚存活,平均裂解细胞较少。在来自三个不同中心的临床研究中,81.4%的玻璃化冷冻囊胚解冻后保持完整。在43次移植中,共移植了76个囊胚,44.7%的囊胚着床,43.4%的囊胚出现胎心,总共已分娩或正在孕育32名婴儿。每次移植的总体临床妊娠率为60.4%。这种新的、安全且易于使用的玻璃化冷冻程序所获得的高存活率和临床妊娠率令人鼓舞。